Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a ...

BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share.

Nov 6 (Reuters) - Industrial software maker PTC (PTC.O), opens new tab forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in demand for its industrial design ...

Engineering and design software provider PTC (NASDAQ:PTC) will be reporting results tomorrow afternoon. Here’s what to look for. PTC missed analysts’ revenue expectations by 2.8% last quarter ...

For the quarter, PTC anticipates revenues to be between $598 million and $648 million. Non-GAAP earnings per share (EPS) are expected to be between $1.30 and $1.66. The Zacks Consensus Estimate ...

In other PTC news, Director Janice Chaffin sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $171.34 ...

PTC Stock Up 2.2 % Shares of NASDAQ PTC opened at $189.35 on Wednesday. The stock has a market capitalization of $22.75 billion, a price-to-earnings ratio of 77.29, a P/E/G ratio of 2.75 and a ...

(Reuters) -Royalty Pharma said on Thursday it has purchased additional royalties on Roche and PTC Therapeutics (NASDAQ:PTCT)' oral spinal muscular atrophy (SMA) drug for an ...

PTC Forecasts Quarterly Revenue Below Estimates on Tight Tech Spending (Reuters) - Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued ...